BARACK D

• Research type

  Research Study

• Full title

  Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) Trial: a prospective randomised open blinded endpoint trial to determine the effect of aldosterone receptor antagonism on mortality and cardiovascular outcomes in patients with stage 3b chronic kidney disease.

• IRAS ID

  107072

• Contact name

  Richard Hobbs

• Contact email

  richard.hobbs@phc.ox.ac.uk

• Sponsor organisation

  University of Oxford, Clinical Trials and Research Governance Office

• Eudract number

  2012-002672-13

• ISRCTN Number

  ISRCTN44522369

• REC name

  South Central - Oxford B Research Ethics Committee

• REC reference

  13/SC/0114

• Date of REC Opinion

  9 Apr 2013

• REC opinion

  Further Information Favourable Opinion